CNB Bank’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CNB Bank's IBB Position: Q4 2024 in Review
CNB Bank sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 13 shares — an estimated $1.89K sold.
CNB Bank first reported a position in IBB in Q4 2018 and held it in 22 quarters. The position peaked at $263K in Q4 2020. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- CNB Bank reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
- CNB Bank sold 13 iShares Biotechnology ETF shares in Q4 2024, an estimated $1.89K.
- CNB Bank first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 22 quarters.
- CNB Bank's iShares Biotechnology ETF position peaked at $263K in Q4 2020.
- 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on CNB Bank's 13F filing for Q4 2024, filed 15 Jan 2025.